Form 8-K Blueprint Medicines Corp For: May 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Blueprint Medicines (BPMC) Tops Q1 EPS by 13c
May 10, 2016 8:45 AM EDTBlueprint Medicines (NASDAQ: BPMC) reported Q1 EPS of ($0.57), $0.13 better than the analyst estimate of ($0.70). Revenue for the quarter came in at $6.86 million versus the consensus estimate of $3.24 million.
Blueprint Medicines expects that its cash, cash equivalents and investments balance will be at least $120 million at... More
